292 related articles for article (PubMed ID: 17628443)
1. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.
Ihn H
J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443
[TBL] [Abstract][Full Text] [Related]
2. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
Ihn H
Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.
Ihn H
Curr Rheumatol Rep; 2005 Apr; 7(2):156-62. PubMed ID: 15760596
[TBL] [Abstract][Full Text] [Related]
4. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of skin fibrosis in systemic sclerosis.
Jinnin M
J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of fibrosis: role of TGF-beta and CTGF.
Ihn H
Curr Opin Rheumatol; 2002 Nov; 14(6):681-5. PubMed ID: 12410091
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
10. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
13. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
14. [Transforming growth factor-beta and its receptors in scleroderma].
QIAN H; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
[TBL] [Abstract][Full Text] [Related]
15. Hypothesis: pathogenesis of systemic sclerosis.
Takehara K
J Rheumatol; 2003 Apr; 30(4):755-9. PubMed ID: 12672195
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in fibroblast signaling and biology in scleroderma.
Pannu J; Trojanowska M
Curr Opin Rheumatol; 2004 Nov; 16(6):739-45. PubMed ID: 15577613
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
[TBL] [Abstract][Full Text] [Related]
18. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
[TBL] [Abstract][Full Text] [Related]
19. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
[TBL] [Abstract][Full Text] [Related]
20. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
